Allotment of Securities
CapitalWatchNotablemateriality 63 out of 100
What happened
FactAllotment of Securities. Equity Shares of face value of Rs. 10 each (“Equity Shares”) at a price of Rs. 1,610 per Equity Share. capital of the Company stands increased from Rs. 26,38,16,740 to Rs. 27,38,16,740.
Why it matters
CapitSignal interpretationRaising capital changes the share count or the debt load, and the stated use of proceeds is a commitment that can later be checked.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
ContradictedEarlierQ1 FY27
Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
NowQ1 FY27
Dahej Phase 1 project cost stands at INR 428 crore with target completion by February 2027, while Pakhajan Phase 2 is budgeted at INR 1,367 crore with completion expected by March 2027
Change
FactFact conflict
Implication
CapitSignal interpretationThe current statement introduces a new project, Dahej Phase 1, with a cost of INR 428 crore, which was not mentioned in the earlier statement. This creates a conflict regarding the focus of the capex discussion.
Watch next
Fact- Instrument and amount finally raised
- Stated use of proceeds
- Whether the enabling resolution is actually used
- 1,000 MT to be commissioned by H2 FY27 (management committed by H2 FY27)
- Looking ahead, as the replacement Dahej plant begins regular commercial operations and Neogen Ionics (NIL) cap (management committed by H2 FY27)
Evidence
- Neogen Chemicals Limited has informed the Exchange regarding allotment of 10,00,000 equity shares pursuant to Preferential Issue at its Fund Raising Committee meeting held on April 18, 2026(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- FUNDRAISE base 58; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%